Sign In
Buy TNXP
$12.20
+0.190 (+1.58%)
At Close: Jun 22, 2026
Tonix Pharma's COVID-19 Vaccine Candidate Shows Encouraging Efficacy In Animal Studies
09:35am, Wednesday, 17'th Mar 2021
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) jumps in premarket trading after announcing positive preliminary results following vaccination of non-human primates with TNX-1800, its COVID-19 v
TNXP Stock Price Increases Over 5% Pre-Market: Why It Happened
07:47am, Wednesday, 17'th Mar 2021
The stock price of Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has increased by over 5% pre-market. This is why it happened.
Vaccine Candidate TNX-1800 Protected Both Upper and Lower Airways After Challenge with SARS-CoV-2, Suggesting an Ability to Block Forward Transmission
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
04:45pm, Monday, 15'th Mar 2021
Announced Positive Phase 3 RELIEF Study Results for TNX-102 SL 5.6 mg in Fibromyalgia
TNXP Stock Price Increases Over 10% Pre-Market: Why It Happened
08:08am, Thursday, 11'th Feb 2021
The stock price of Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) is trading at over 10% pre-market. This is why it happened.
Tonix Pharma Shares Rally After In-Licensing Of Technology For A Rare Genetic Eating Disorder
07:50am, Thursday, 11'th Feb 2021
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has licensed technology using oxytocin-based therapeutics from the French National Institute of Health and Medical Research (Inserm) for the treatm
Expands Proprietary Uses of Tonix's Potentiated Oxytocin for Intranasal Administration
Tonix Pharmaceuticals to Participate in BIO CEO & Investor Digital Conference
07:00am, Wednesday, 10'th Feb 2021
CHATHAM, N.J., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederm
Tonix Pharmaceuticals Holdings Corp. Closes $70M Common Stock Offering Priced At-The-Market Under Nasdaq Rules
04:05pm, Tuesday, 09'th Feb 2021
CHATHAM, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) -- TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) (“Tonix” or the “Company”), a clinical-stage biopharmaceutical company, today announced t
Why Tonix Pharmaceuticals Stock Surged Today
08:09pm, Monday, 08'th Feb 2021
The biotech wants to help doctors measure T-cell immunity to the novel coronavirus.
Tonix Pharmaceuticals $70M; Plans To Develop COVID-19 Skin Test
01:15pm, Monday, 08'th Feb 2021
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has entered into a securities purchase agreement with institutional investors to purchase 58.3 million shares at $1.20 per share, raising gross pr
Tonix Pharmaceuticals Holdings Corp. Prices $70M Common Stock Offering Priced At-The-Market Under Nasdaq Rules
10:30am, Monday, 08'th Feb 2021
CHATHAM, N.J., Feb. 08, 2021 (GLOBE NEWSWIRE) -- TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) (“Tonix” or the “Company”), a clinical-stage biopharmaceutical company, today announced i
TNXP Stock: Why Tonix Pharmaceuticals Shares Are on the Move Today
09:20am, Thursday, 04'th Feb 2021
TNXP stock is on the move today as investors speculate over potential patent approval and Tonix's drug candidate for Alzheimer's. The post TNXP Stock: Why Tonix Pharmaceuticals Shares Are on the Move
TNXP Stock Price Increases Over 30% Pre-Market: Why It Happened
05:23am, Thursday, 04'th Feb 2021
The stock price of Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) is trading at over 30% pre-market today as of 5:06 AM ET. This is why it happened.
Tonix Pharmaceuticals CEO Believes That Additional COVID-19 Vaccine Research Is Still Needed
08:51am, Tuesday, 02'nd Feb 2021
Tonix Pharmaceuticals was one of the sponsors for the Benzinga Global Small Cap Conference that took place on December 8-9, 2020. The information contained in this article in no way represents investm
